Increased intracranial pressure: Difference between revisions
From IDWiki
(Imported from text file) |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
Line 1: | Line 1: | ||
== Clinical |
== Clinical Manifestations == |
||
* Headache |
* Headache |
Latest revision as of 16:13, 16 July 2020
Clinical Manifestations
- Headache
- Nausea/vomiting
- Cushing response
- Hypertension
- Bradycardia
- Irregular respiration
Management
- Invasive monitoring of ICP
- Indications
- At risk for elevated ICP
- Comatose
- Prognosis not hopeless
- Contraindications
- Bleeding diathesis or anticoagulation
- Risks
- Intracranial hemorrhage (1-2%)
- Devices
- Intraventricular catheters
- Parenchymal monitors
- Extra-axial devices
- Non-invasic TCD of JvO2
- Aim for ICP < 20 while maintaining cerebral perfusion pressure > 70
- Based on extra-auditory meatus
- Indications
- Decrease intracerebral contents
- Vascular
- Elevate head of bed
- Hyperventilation to pCO2 30-40 (though can go lower acutely)
- CSF
- Reduce CSF production with furosemide or acetazolamide
- CSF drainage
- Parenchyma
- Remove the mass or create space
- Osmotic diuresis with mannitol and 3% saline
- Brain volume
- Hypertonic saline 3% 5ml/kg
- Mannitol 1g/kg
- Vascular
- Increase skull capacity
- Craniectomy or decompression
- Decrease oxygen demand
- Deep sedation with propofol or barbiturates
- Hypothermia
- Paralysis (decreases systemic demand meaning more oxygen available to the brain)